Honeycrisp apple genome was completed
On Oct. 13, 2022, a team of researchers led by Cornell University announced they had sequenced the Honeycrisp…
Pfizer and BioNTech announced positive early data from clinical trial of Omicron BA.4/BA.5-adapted bivalent booster
On Oct. 13, 2022, Pfizer and BioNTech announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating…
Researchers developed method to study brain connectivity, functionality
On Oct. 12, 2022, scientists announced they had developed a research method that allows for a much more…
Biotechnology | CDC | COVID-19 | FDA
Pfizer and BioNTech received U.S. FDA EUA for Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster in children
On Oct. 12, 2022, Pfizer and BioNTech announced that the U.S. Food and Drug Administration granted Emergency Use…
Hutchinson Cancer Center announced $710.5 million gift to support cancer and infectious disease research, ‘skin-on-chip’ technology
On Oct. 12, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced the Bezos family had committed $710.5 million…
Moderna received Authorization for Emergency Use from FDA of Omicron-targeting bivalent COVID-19 booster vaccine for children
On Oct. 12, 2022, Moderna announced that it had received emergency use authorization from the U.S. Food and…
Intranasal COVID-19 vaccine candidateﾒs clinical data highlighted need for further development of nasal spray vaccines
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
Roche launched next-generation portfolio of SARS-CoV-2 rapid antigen tests
On Oct. 11, 2022, Roche announced the launch of its next-generation portfolio SARS-CoV-2 rapid antigen tests (ﾓ2.0ﾔ) for…
Novavax and SK bioscience filed post approval change application in South Korea for Nuvaxovid COVID-19 vaccine as booster in adults
On Oct. 10, 2022, Novavax announced that partner, SK bioscience, had submitted a Post Approval Change Application to…
Mayo Clinic received $100 million gift from Fred C. and Katherine B. Andersen Foundation to expand proton beam therapy services
On Oct. 10, 2022, the Mayo Clinic announced that The Fred C. and Katherine B. Andersen Foundation of…
Switzerland’s Federal Office of Public Health recommended Novavax Nuvaxovid COVID-19 vaccine as booster in adults
On Oct. 10, 2022, Novavax announced that Switzerland’s Federal Office of Public Health had recommended Nuvaxovid (NVX-CoV2373) as…
Pfizer and BioNTech’s Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster received Health Canada authorization for individuals 12 years of age and older
On Oct. 7, 2022, Pfizer and BioNTech announced that Health Canada had authorized COMIRNATY Original & Omicron BA.4/BA.5…
FDA Authorized PCR-Based Mpox Test
On Oct. 7, 2022, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to…
FDA approved vaccine for use during third trimester of pregnancy to prevent whooping cough in infants
On Oct. 7, 2022, the U.S. Food and Drug Administration approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and…
USDA confirmed highly pathogenic Avian influenza in commercial chickens in Arkansas
On Oct. 7, 2022, the U.S. Department of Agricultures Animal Plant Health Inspection Service (APHIS) confirmed the presence…
3D map revealed DNA organization within human retina cells
On Oct. 7, 2022, the National Eye Institute researchers announced they had mapped the organization of human retinal…
Japanese vaccine database Created to assess Vaccine Effectiveness and adverse events
On Oct. 6, 2022, researchers in Japan released a study that described the development and application of the…
Merck and Ridgeback Biotherapeutics provided update on new clinical and non-clinical studies of LAGEVRIOﾙ (molnupiravir)
On Oct. 6, 2022, Merck announced data from two real-world evidence studies evaluating LAGEVRIOﾙ (molnupiravir), an investigational oral…
WHO warned of deadly cholera outbreak in Lebanon as cases increase
On Oct. 6, 2022, the World Health Organization announced the first cholera outbreak in nearly three decades in…
Nobel Prize in Chemistry was awarded to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry”
On Oct. 5, 2022, the Nobel Prize in Chemistry was awarded jointly to Carolyn R. Bertozzi, Morten Meldal…
Drought exacerbated emerging infectious disease in California
On Oct. 5, 2022, researchers at UC Berkeley reported that coccidioidomycosisﾗalso known as Valley feverﾗan infectious disease, was…
Washington University in St. Louis COVID-19 nasal vaccine technology licensed to Ocugen
On Oct. 4, 2022, Washington University in St. Louis announced it had licensed the rights to develop, manufacture…
USDA opened new poultry research facility in Georgia
On Oct. 4, 2022, the United States Department of Agriculture’s (USDA) Agricultural Research Service (ARS), Southeast Poultry Research…
The Nobel Prize in Physiology or Medicine awarded to Svante Paabo “for his discoveries concerning the genomes of extinct hominins and human evolution”
On Oct. 3, 2022, the Nobel Prize in Physiology or Medicine was awarded to was awarded to Svante…
Monica Bertagnolli began work as 16th director of the National Cancer Institute
On Oct. 3, 2022, Monica M. Bertagnolli, M.D., started as the 16th director of the National Cancer Institute….
FDA Modernization Act reauthorized the Prescription Drug User Fee Act of 2017
On Sept. 30, 2022, the U.S. Food and Drug Administration Modernization Act reauthorized the Prescription Drug User Fee…
Biotechnology | Disease | WHO
WHO launched new initiative to stop the spread of invasive malaria vector in Africa
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…
USDA confirmed two cases of highly pathogenic avian influenza in neighboring non-commercial flocks in Tillamook County
On Sept. 28, 2022, the Oregon Department of Agriculture and the U.S. Department of Agriculture’s Animal Plant Health…
Pfizer and BioNTech completed submission to EMA for Omicron BA.4/BA.5-adapted bivalent vaccinebBooster in children 5 through 11 years of age
On Sept. 28, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
EMA accepted Moderna’s conditional Marketing Authorization filing for omicron BA.4/BA.5 targeting bivalent COVID-19 vaccine
On Sept. 28, 2022, Moderna announced that the European Medicines Agency (EMA) had accepted a variation for the…